The Current Status of New Antidiabetic Drugs

키워드

참고문헌 (8)

1. "Diabetes: facts and figures" (2015)[URL]
2. Kabadi UM, "Sulfonylurea glimepiride: a proven cost effective, safe and reliable war horse in combating hyperglycemia in type 2 diabetes", J Diabetes Mellitus, 5(4), pp.211~226 (2015)
3. Pemminati S, "Gangachannaiah S. Are the newer antidiabetic agents worth the cost", J Clin Diagn Res, 10(3) (2016)[DOI]
4. Zhang Y, "Second-line agents for glycemic control for type 2 diabetes: are newer agents better", Diabetes Care, 37(5), pp.1338~1345 (2014)
5. Chowdhary M, "Canagliflozin-induced pancreatitis: a rare side effect of a new drug", Ther Clin Risk Manag, 11, pp.991~994 (2015)
6. Pemminati S, "Metabolic syndrome among inmates of a ‘home for aged’ using IDF 2005 criteria", Nepal Med Coll J, 11(1), pp.31~33 (2009)
7. Pemminati S, "Prevalence of metabolic syndrome (METS) using IDF 2005 guidelines in a semi urban south Indian (boloor diabetes study) population of Mangalore", J Assoc Physicians India, 58, pp.674~677 (2010)
8. Guettier JM, "Polymorphisms in the fatty acid-binding protein 2 and apolipotrotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population", J Clin Endocrinol Metab, 90(3), pp.1705~1711 (2005)

관련 논문AI추천